The Application dimension of the Pharmaceutical Coating market is divided into three primary sub‑segments: oral solid dosage forms, injectable dosage forms, and topical dosage forms. Oral solid dosage forms, which include tablets and capsules, dominate the market, accounting for roughly 70 % of total revenue due to their high volume, established manufacturing lines, and broad therapeutic coverage. Injectable dosage forms, encompassing vials, ampoules, and pre‑filled syringes, represent about 20 % of the market; their growth is driven by increasing biologics and vaccine production, which require sterile, protective coating solutions. Topical dosage forms such as creams, gels, and transdermal patches contribute the remaining 10 %, reflecting niche applications where coating enhances skin adhesion, controlled release, or aesthetic properties. Together, these application categories shape the overall market size, with each segment’s share reflecting both product demand and the technical complexity of the coating processes involved. This breakdown is central to any comprehensive Pharmaceutical Coating segmentation analysis.
